Yunis-Varon syndrome

Yunis-Varon syndrome (YVS) is an extremely rare, severe autosomal recessive multisystem disorder characterized by skeletal defects, ectodermal anomalies, and severe neurological impairment. The condition was first described by Yunis and Varon in 1980. It is caused by biallelic mutations in the FIG4 gene (also known as SAC3), which encodes a phosphoinositide phosphatase critical for endosomal-lysosomal membrane trafficking and autophagy. Loss of FIG4 function leads to accumulation of enlarged vacuoles in neurons and other cell types, contributing to progressive neurodegeneration. The hallmark features of Yunis-Varon syndrome include cleidocranial dysplasia (absent or hypoplastic clavicles), aplasia or hypoplasia of the thumbs and great toes, absence or hypoplasia of the distal phalanges of the fingers and toes, and deficient ossification of the skull (wide fontanelles and sutures). Ectodermal findings include sparse hair, thin or absent eyebrows, and abnormalities of the lips. Affected infants typically present with severe feeding difficulties, profound hypotonia, and progressive neurological deterioration. Cardiac involvement, including cardiomyopathy, has been reported in some patients. Facial features may include micrognathia, a short philtrum, thin lips, and low-set ears. The prognosis for Yunis-Varon syndrome is very poor, with most affected infants dying in the neonatal period or early infancy due to respiratory failure, cardiac complications, or progressive neurodegeneration. There is currently no specific or curative treatment available. Management is supportive and symptomatic, focusing on nutritional support, respiratory care, and management of cardiac complications. Genetic counseling is recommended for affected families.

Common questions about Yunis-Varon syndrome